Envoy Medical (COCH) Institutional Ownership $3.27 -0.08 (-2.39%) (As of 09/13/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Envoy Medical (NASDAQ:COCH)CurrentInstitutional OwnershipPercentage8.59%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$135.63KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$103.59K Get COCH Insider Trade Alerts Want to know when executives and insiders are buying or selling Envoy Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade Envoy Medical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2024 Atlas Merchant Capital LLC555,527$1.31M0.5%-7.3%2.834% 5/20/2024 Virtu Financial LLC14,045$55K0.0%N/A0.072% 5/3/2024 WealthTrust Asset Management LLC11,316$44K0.0%N/A0.058% 2/12/2024 Weiss Asset Management LP20,000$37K0.0%N/A0.102% (Data available from 1/1/2016 forward) COCH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of COCH shares? During the previous two years, the following institutional investors and hedge funds held shares of Envoy Medical shares: Atlas Merchant Capital LLC ($1.31M), Virtu Financial LLC ($55K), and WealthTrust Asset Management LLC ($44K), Weiss Asset Management LP ($37K).Learn more on COCH's institutional investors. What percentage of Envoy Medical stock is owned by institutional investors? 8.59% of Envoy Medical stock is owned by institutional investors. Learn more on COCH's institutional investor holdings. Which institutional investors have been buying Envoy Medical stock? The following institutional investors have purchased Envoy Medical stock in the last 24 months: Weiss Asset Management LP ($20K), Virtu Financial LLC ($14.05K), and WealthTrust Asset Management LLC ($11.32K). How much institutional buying is happening at Envoy Medical? Institutional investors have bought a total of 45,361 shares in the last 24 months. This purchase volume represents approximately $135.63K in transactions. Which Envoy Medical major shareholders have been selling company stock? The following institutional investors have sold Envoy Medical stock in the last 24 months: Atlas Merchant Capital LLC ($43.89K). How much institutional selling is happening at Envoy Medical? Institutional investors have sold a total of 43,892 shares in the last 24 months. This volume of shares sold represents approximately $103.59K in transactions. Related Companies: NeuroPace Institutional Ownership Nevro Institutional Ownership Profound Medical Institutional Ownership Beauty Health Institutional Ownership Semler Scientific Institutional Ownership CVRx Institutional Ownership Alpha Tau Medical Institutional Ownership Electromed Institutional Ownership Lakeland Industries Institutional Ownership BrainsWay Institutional Ownership This page (NASDAQ:COCH) was last updated on 9/15/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Turn Smartphones Into “Earnphones”?High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.